Flemish population-based cancer screening programs: impact of COVID-19 related shutdown on short-term key performance

Svetlana Jidkova1,2, Sarah Hoeck3,4, Eliane Kellen3,5

  • 1Department of Public Health and Primary Care, Ghent University, Ghent, Belgium. svetlana.jidkova@ugent.be.

BMC Cancer
|February 18, 2022
PubMed
Abstract

Insights

COVID-19 disrupted cancer screening invitations, particularly for breast cancer, reducing coverage. However, willingness to screen remained high, and screening intervals returned to normal, suggesting minimal long-term impact on cancer diagnosis risks.

Area of Science:

  • Public Health
  • Epidemiology
  • Cancer Screening

Background:

  • COVID-19 pandemic led to significant disruptions in established breast, colorectal, and cervical cancer screening programs.
  • Temporary shutdowns of screening invitations occurred between March and May-June in Flanders, Belgium.
  • The study assesses the immediate effects of these disruptions on screening program performance.

Purpose of the Study:

  • To estimate the short-term impact of the COVID-19 pandemic-related shutdown on cancer screening programs in Flanders.
  • To analyze changes in invitation coverage, screening response rates, and screening intervals.
  • To evaluate the influence of the pandemic on population-level cancer screening adherence.

Main Methods:

  • Invitation coverage calculated as the proportion of intended invitations sent.
  • Weekly response to invitation (willingness to screen) measured as screening within 40 days of invitation.
  • Weekly screening interval calculated as the mean time between consecutive screenings.
  • Comparison of 2020 data with 2019 data, stratified by gender, age, and participation history.

Main Results:

  • Invitation coverage remained stable for colorectal and cervical cancer screening but decreased significantly for breast cancer screening (97.5% to 88.7%).
  • Willingness to screen showed minimal influence from the pandemic.
  • A temporary increase in the breast cancer screening interval (average 2.1 months longer) was observed post-shutdown.

Conclusions:

  • While willingness to screen was minimally affected, reduced invitation coverage, especially for breast cancer screening, poses a potential concern.
  • Observed increases in screening intervals appear manageable and unlikely to significantly elevate the risk of delayed cancer diagnoses.
  • Continuous monitoring is essential when resuming cancer screening programs after pandemic-related interruptions.